Header Logo

Connection

DOV KADMON to 5-alpha Reductase Inhibitors

Back to Details
This is a "connection" page, showing publications DOV KADMON has written about 5-alpha Reductase Inhibitors.
DOV KADMON
Connection Strength
0.047
5-alpha Reductase Inhibitors
  1. The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial. J Urol. 2002 May; 167(5):2105-8.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.